BioSpace News Archive

Natus Medical Incorporated, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced the appointments of Bryant M. Moore, Ph.D. and Eric J. Guerin to the Company’s Board of Directors.

The US Food and Drug Administration has approved the first-ever pharmaceutical treatment for patients with von Hippel-Lindau disease, a genetic condition putting patients at risk of developing several cancers and other types of tumors.

Cosmos Holdings, Inc., an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, and an extensive, established European Union distribution network, announced that the Company has entered into a debt exchange agreement with its senior lender to further reduce the Company’s debt.

SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a precision medicine company that discovers, develops and commercializes innovative rapid diagnostic testing for healthcare professionals, patients and consumers worldwide, today reported its financial and operational results for the third quarter of fiscal year 2021, ended June 30th, 2021.

These studies highlight the additive effect of the AccumTM technology and guide the selection of the optimal Accum-T-DM1 in vivo testing on breast and gastric cancer models.

Proteintech, the benchmark in antibodies, announces the tripling in size of its Rosemont, Illinois headquarters and laboratories to expand its antibody conjugation capabilities, increase GMP protein operations and add clinical capabilities to its antibodies’ portfolio, including IBVR and ASR.

International Isotopes Inc. announces its financial results for the three months ended June 30, 2021.

Increase in prevalence of eye diseases such as dry eye syndrome and allergic conjunctivitis drives the growth of the global OTC artificial tears market,

On the other hand, poor demand in underdeveloped countries restrains the growth to some extent. However, several growth opportunities in emerging markets have proven to be beneficial for the market growth.

Surge in obese population and increase in sport related injuries are the factors driving the growth of the soft tissue repair market.